GSK plc (GSK.L) Stock Forecast
LSE · Healthcare
Current price
£19.84
Market cap
£79.47B
Mean price target
£20.87
Implied upside
5.2%
Key takeaways
- Analysts rate GSK plc a “Hold”, with a mean price target of £20.87 — about 5.2% upside from the current £19.84, based on 19 analysts.
- GSK.L is trading in the middle of its 52-week range, at 70% of the £12.89–£22.82 band.
Analyst consensus
| Consensus rating | Hold |
|---|---|
| Number of analysts | 19 |
| Mean target | £20.87 |
| High target | £28.25 |
| Low target | £14.55 |
| Rating split (SB / B / H / S / SS) | 0 / 5 / 13 / 2 / 2 |
Price & trading
| Current price | £19.84 |
|---|---|
| Previous close | £19.50 |
| 52-week high | £22.82 |
| 52-week low | £12.89 |
| 50-day average | £19.37 |
| Beta | 0.29 |
See the full GSK.L breakdown on Luminoso
Valuation, profitability, efficiency, leverage & earnings-quality metrics — updated daily.
Start free — 2 months on usFrequently asked questions
- What is the current GSK plc (GSK.L) share price?
- GSK plc last traded at £19.84 with a market capitalisation of about £79.5B.
- What is the analyst price target for GSK.L?
- The mean analyst price target for GSK plc is £20.87, roughly 5.2% above the latest price. The current consensus rating is “Hold”.
- Where can I see GSK plc's full financial metrics?
- Luminoso tracks GSK.L's valuation, profitability, efficiency, leverage and earnings-quality metrics alongside analyst data — updated daily. Create a free account to explore the full breakdown.
More stocks
Browse all companies covered by Luminoso →
Last updated 25 Jun 2026.
Data is provided for informational purposes only and is not investment advice. Figures are cached and refreshed daily; they may differ from real-time quotes.